Alzheimer's disease (AD) is a great threat for the health and life of elderly people. MicroRNA-
128 (miR-128) has been reported to be abnormally expressed in the brain of AD patients …

Purpose Alzheimer's disease (AD) is the sixth most common cause of death in the United
States. MicroRNAs have been identified as vital players in neurodegenerative diseases …

MicroRNA-455-3p (miR-455-3p) is identify as a member of broadly conserved miRNA family
expressed in most of the phylum and species. In humans, miR-455 is present on the human …

Objective: Alzheimer's disease (AD), also known as senile dementia, is a common
neurodegenerative disease characterized by progressive cognitive impairment and …

Alzheimer's disease (AD) pathogenesis is known to involve a dysregulation of microRNA
expression, and these intricate transcriptional cascades between multiple pathological …

Alzheimer's disease (AD) is a neurodegenerative condition leading to severe disability from
progressive impairments in cognitive functions including memory and learning. Non-coding …

MicroRNAs (miRs) are a class of endogenous small non-coding RNAs that have been
revealed to negatively mediate the expression of their target genes at the post …

Growing evidence indicates that overexpression of the microRNA-34 (miR-34) family in the
brain may play a crucial role in Alzheimer's disease (AD) pathogenesis by targeting and …

Numerous studies have reported that miR-125b is elevated in different brain regions of AD
patients compared to healthy individuals (Lukiw and Alexandrov, 2012; Richardson et al …

Alzheimer's disease (AD) is a form of dementia characterized by progressive memory
decline and cognitive dysfunction. With only one FDA-approved therapy, effective treatment …